Platelet Reactivity and Outcomes After Off-Pump Coronary Surgery in Acute Coronary Syndrome Patients

Overview

Journal J Clin Med

Specialty General Medicine

Date 2022 Jun 24

PMID 35743360

Authors

Sarah Soh

Yu Rim Shin

Jong-Wook Song

Jun Hyug Choi

Young-Lan Kwak

Jae-Kwang Shim

Affiliations

Soon will be listed here.

Abstract

Ischemic and hemorrhagic complications are major determinants of survival in acute coronary syndrome (ACS) patients undergoing coronary surgery. We investigated the association of preoperative platelet reactivity to P2Y antagonists with ischemic and hemorrhagic complications after Off-Pump Coronary Artery Bypass surgery (OPCAB) in ACS patients who received dual anti-platelet therapy (DAPT) within 5 days prior to surgery. This prospective, observational study with 177 patients compared the incidence of perioperative major bleeding and major adverse cardiac events (MACEs) in relation to the tertile distribution of the % inhibitory response to P2Y antagonists, as measured by a thromboelastography platelet mapping assay. The incidences of perioperative major bleeding and MACEs were similar in relation to the tertile distribution of inhibitory response to P2Y antagonists. The % inhibitory responses to P2Y antagonists between patients who did or did not exhibit MACEs, and with or without major bleeding, were 58 ± 20% and 56 ± 20% ( = 0.578) and 57 ± 19% and 56 ± 21% ( = 0.923), respectively. In ACS patients who received DAPT close to OPCAB, the platelet inhibitory response to P2Y antagonists was not associated with ischemic or hemorrhagic complications. OPCAB may obviate the need for routine platelet function testing for ACS patients requiring DAPT and surgical revascularization. Clinical Registration Number: NCT02184884.

References

Kapetanakis E, Medlam D, Petro K, Haile E, Hill P, Dullum M . Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae?. Circulation. 2006; 113(13):1667-74. DOI: 10.1161/CIRCULATIONAHA.105.571828. View

Shim J, Choi Y, Oh Y, Bang S, Yoo K, Kwak Y . Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery. J Thorac Cardiovasc Surg. 2007; 134(1):59-64. DOI: 10.1016/j.jtcvs.2007.03.013. View

Maltais S, Perrault L, Do Q . Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery. Eur J Cardiothorac Surg. 2008; 34(1):127-31. DOI: 10.1016/j.ejcts.2008.03.052. View

Mahla E, Suarez T, Bliden K, Rehak P, Metzler H, Sequeira A . Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated.... Circ Cardiovasc Interv. 2012; 5(2):261-9. DOI: 10.1161/CIRCINTERVENTIONS.111.967208. View

Dyke C, Aronson S, Dietrich W, Hofmann A, Karkouti K, Levi M . Universal definition of perioperative bleeding in adult cardiac surgery. J Thorac Cardiovasc Surg. 2013; 147(5):1458-1463.e1. DOI: 10.1016/j.jtcvs.2013.10.070. View

Valgimigli M, Bueno H, Byrne R, Collet J, Costa F, Jeppsson A . 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the.... Eur Heart J. 2017; 39(3):213-260. DOI: 10.1093/eurheartj/ehx419. View

Kremke M, Tang M, Bak M, Lawaetz Kristensen K, Hindsholm K, Andreasen J . Antiplatelet therapy at the time of coronary artery bypass grafting: a multicentre cohort study. Eur J Cardiothorac Surg. 2013; 44(2):e133-40. DOI: 10.1093/ejcts/ezt230. View

Urban P, Mehran R, Colleran R, Angiolillo D, Byrne R, Capodanno D . Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. Eur Heart J. 2019; 40(31):2632-2653. PMC: 6736433. DOI: 10.1093/eurheartj/ehz372. View

Mannacio V, Meier P, Antignano A, Tommaso L, De Amicis V, Vosa C . Individualized strategy for clopidogrel suspension in patients undergoing off-pump coronary surgery for acute coronary syndrome: a case-control study. J Thorac Cardiovasc Surg. 2014; 148(4):1299-306. DOI: 10.1016/j.jtcvs.2013.12.011. View

10.

Tantry U, Bonello L, Aradi D, Price M, Jeong Y, Angiolillo D . Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol. 2013; 62(24):2261-73. DOI: 10.1016/j.jacc.2013.07.101. View

11.

Levine G, Jeong Y, Goto S, Anderson J, Huo Y, Mega J . Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol. 2014; 11(10):597-606. DOI: 10.1038/nrcardio.2014.104. View

12.

Kwak Y, Kim J, Choi Y, Yoo K, Song Y, Shim J . Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery. J Am Coll Cardiol. 2010; 56(24):1994-2002. DOI: 10.1016/j.jacc.2010.03.108. View

13.

Fox K, Mehta S, Peters R, Zhao F, Lakkis N, Gersh B . Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation. 2004; 110(10):1202-8. DOI: 10.1161/01.CIR.0000140675.85342.1B. View

14.

Malm C, Hansson E, Akesson J, Andersson M, Hesse C, Shams Hakimi C . Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study. Br J Anaesth. 2016; 117(3):309-15. DOI: 10.1093/bja/aew189. View

15.

Kellum J, Lameire N . Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013; 17(1):204. PMC: 4057151. DOI: 10.1186/cc11454. View

16.

Thygesen K, Alpert J, Jaffe A, Chaitman B, Bax J, Morrow D . Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018; 72(18):2231-2264. DOI: 10.1016/j.jacc.2018.08.1038. View

17.

Eisen A, Giugliano R, Braunwald E . Updates on Acute Coronary Syndrome: A Review. JAMA Cardiol. 2016; 1(6):718-30. DOI: 10.1001/jamacardio.2016.2049. View

18.

Ferraris V, Saha S, Oestreich J, Song H, Rosengart T, Reece T . 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg. 2012; 94(5):1761-81. DOI: 10.1016/j.athoracsur.2012.07.086. View

19.

Aradi D, Kirtane A, Bonello L, Gurbel P, Tantry U, Huber K . Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. Eur Heart J. 2015; 36(27):1762-71. DOI: 10.1093/eurheartj/ehv104. View

20.

Morici N, Moja L, Rosato V, Oreglia J, Sacco A, De Marco F . Time from adenosine di-phosphate receptor antagonist discontinuation to coronary bypass surgery in patients with acute coronary syndrome: meta-analysis and meta-regression. Int J Cardiol. 2013; 168(3):1955-64. DOI: 10.1016/j.ijcard.2012.12.087. View